NCT02393261

Brief Summary

This prospective, randomized, controlled, multi-center clinical trial will evaluate the validity and security of 2500ml Huaren Peritoneal Dialysate compared with normal 2000ml peritoneal dialysate.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 9, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 19, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

March 19, 2015

Status Verified

March 1, 2015

Enrollment Period

5 months

First QC Date

March 9, 2015

Last Update Submit

March 18, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adequacy of dialysis (kt/v)

    kt/v

    up to 8 weeks

Secondary Outcomes (2)

  • Residual kidney function (Residual kidney kt/v)

    up to 6 months

  • Peritoneal function (Peritoneal equilibration test)

    up to 6 months

Study Arms (2)

A 2500mlGroup

EXPERIMENTAL

use 2-3 bags of 2500ml Huaren dialysate in the daytime and keep 1 bag of 2500ml Huaren dialysate in the night

Other: 2500ml Huaren peritoneal dialysate

B 2000mlGroup

ACTIVE COMPARATOR

use 3-4 bags of normal 2000ml dialysate in the daytime and keep 1 bag of 2000ml dialysate in the night

Other: 2000ml peritoneal dialysate

Interventions

use 2-3 bags of 2500ml Huaren dialysate in the daytime and keep 1 bag of 2500ml Huaren dialysate in the night

A 2500mlGroup

use 3-4 bags of normal 2000ml dialysate in the daytime and keep 1 bag of 2000ml dialysate in the night

B 2000mlGroup

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The duration of PD is more than 1 month.
  • The age is range from 18 to 80 years old.
  • The patient can be treated with regular PD in home.
  • The volume of peritoneal dialysate is from 8L to 10 L in 1 day.
  • The patient can be visited regularly.
  • The patient must be freely given informed consent

You may not qualify if:

  • Peritonitis was happened within 1 month
  • The KT/V\<1.7
  • Infections in the exit or tunnel
  • With tumors.
  • With low transport of peritoneum.
  • With mental and behavior disorders.
  • With acute renal failure
  • Hemodialysis meanwhile
  • With heart failure( NYHA III-IV ) or cardio- cerebrovascular events
  • Attending other clinical trails
  • Refused to give informed consent Exit criteria
  • (1)Stop PD for more than 10 days (2)The patient demand to quit from the RCT (3)With serious adverse events.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nephrology, 6th Affiliated Hospital, Sun Yat-Sen University

Guangzhou, Guangdong, 510655, China

RECRUITING

MeSH Terms

Interventions

Dialysis Solutions

Intervention Hierarchy (Ancestors)

Pharmaceutical SolutionsSolutionsPharmaceutical PreparationsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesSpecialty Uses of Chemicals

Study Officials

  • Zongpei Jiang, M.D. & Ph.D.

    The Sixth Affiliated Hospital, Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zongpei Jiang, M.D. & Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The Sixth Affiliated Hospital of Sun Yat-Sen University

Study Record Dates

First Submitted

March 9, 2015

First Posted

March 19, 2015

Study Start

January 1, 2015

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

March 19, 2015

Record last verified: 2015-03

Locations